Results 251 to 260 of about 128,988 (349)

Promotion of 5‐hydroxymethylfurfural synthesis from glucose over AlCl3 catalyst with choline chloride

AIChE Journal, EarlyView.
Abstract Efficient production of 5‐hydroxymethylfurfural (HMF) from glucose was achieved in a water‐methyl isobutyl ketone biphasic solvent system over AlCl3 catalyst, using a green and cheap choline chloride (ChCl) salt as a promoter. An optimized HMF yield of 67% was obtained from 0.6 M glucose over 0.06 M AlCl3 with 3.8 M ChCl addition at 140°C ...
Chencong Ruan, Hero Jan Heeres, Jun Yue
wiley   +1 more source

Multidimensional Assessment of Psychiatric Adverse Events Related to Proton Pump Inhibitors: A Real-World, Pharmacovigilance Study. [PDF]

CNS Neurosci Ther
Zhan ZQ, Li JX, Zhang WG, Huang SY, Fang X.   +4 more
europepmc   +1 more source

Proton pump inhibitors: a study of GPs' prescribing

, 2001
Miren I Jones, Sheila Greenfield, Sue Jowett, Colin Bradley, Ruth L. Seal   +4 more
openalex   +1 more source

MEW/PVA‐MA Hydrogel Vascular Grafts: Enhancing Hemocompatibility and Endothelialization

Advanced NanoBiomed Research, EarlyView.
A biomimetic vascular graft combining biofunctionalized PVA‐MA hydrogels with a MEW scaffold is developed for small‐diameter applications. Gel‐MA and Hep‐MA incorporation enhances endothelialization and hemocompatibility, respectively, targeting the acute biological responses.
Verena Kronberger, Shouyuan Jiang, Minh H. Ho, Jasneil Singh, Chung‐Wei (Roy) Hsu, Gabriella C. J. Lindberg, Khoon S. Lim, Tomasz Jungst, Anna Waterhouse   +8 more
wiley   +1 more source

Reducing the use of proton pump inhibitors in infants with gastroesophageal reflux symptoms. [PDF]

Can Fam Physician
Størdal K, Beck CE.
europepmc   +1 more source

COX-2 inhibitor compared with proton pump inhibitor in the prevention of recurrent ulcer complications in high-risk patients taking NSAIDs

, 2001
Kam‐Chuen Lai, Kent‐Man Chu, Wai‐Mo Hui, Chun-Yu Wong, Wayne Hc Hu, Wai-Man Yuen, Man‐Fung Yuen, On-On Chan, Ching–Lung Lai, Ka-Kit Lau, Chi-Kuen Chan, Shiu‐Kum Lam   +11 more
openalex   +1 more source

Author's reply to the "Comment on 'Concomitant use of metformin and proton pump inhibitors increases vitamin B12 deficiency risk in type 2 diabetes'". [PDF]

J Diabetes Investig
Jung C, Park S, Kim H.
europepmc   +1 more source

Laryngeal Manifestations of Gastroesophageal Reflux Disease (GERD) in Pediatric Patients: The Usefulness of Therapeutic (Proton Pump Inhibitor (PPI)) Trials.

, 2001
Hideto Saigusa, Seiji Niimi, Utako Saigusa, Toshiaki Yagi, Toshifumi Takakuwa   +4 more
openalex   +2 more sources

Enhanced gastroprotective and anti-ulcerogenic activities in rats of a new class of proton pump inhibitor containing nitrosothiol nitric oxide donor

, 2001
J. K. Saha, Tiansheng Wang, Richardson Stewart, Mark Trocha, Mathew J. Shumway, David S. Garvey, L. Gordon Letts, M. Michael Wolfe, S. William Tam   +8 more
openalex   +1 more source

Engineering Artificial Mitochondria with Self‐Amplifying Proton Generation for Autonomous Energy Supply and Metabolic Coupling in Artificial Cells

Angewandte Chemie International Edition, EarlyView.
A mitochondria‐mimicking ATP generator improves the enzyme instability of enzyme‐based artificial mitochondria and eliminates the toxicity of H2O2 via quantitative enzyme co‐compartmentalization. The resulting artificial mitochondria can establish a sustained proton gradient for ATP synthesis.
Fangqin Fu, Xuemei Hu, Shijia Tao, Yu Gao, Daniel Crespy, Katharina Landfester, Xiangzhao Mao, Shuai Jiang   +7 more
wiley   +1 more source